This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Katrin Waellnitz: Innovator in On-Demand Contraception
Introduction
Katrin Waellnitz is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the area of contraception. Her innovative approach focuses on providing women with more control over their reproductive health.
Latest Patents
Katrin Waellnitz holds 1 patent for her invention titled "Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception." This invention relates to a method of hormonal female-controlled 'on demand' contraception. It involves a pharmaceutical preparation that combines a COX inhibitor and levonorgestrel, which is taken prior to expected sexual intercourse. The invention also encompasses various pharmaceutical compositions and application regimes for effective 'on demand' contraception.
Career Highlights
Katrin Waellnitz is associated with Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. Her work at Bayer has allowed her to focus on innovative solutions that address women's health needs. Her dedication to research and development has positioned her as a key figure in her field.
Collaborations
Katrin has collaborated with notable colleagues, including Ulrike Fuhrmann and Bernhard Lindenthal. These partnerships have contributed to the advancement of her research and the successful development of her patented invention.
Conclusion
Katrin Waellnitz is a trailblazer in the realm of on-demand contraception, with her innovative patent paving the way for improved reproductive health options for women. Her work at Bayer Pharma and collaborations with esteemed colleagues highlight her commitment to advancing pharmaceutical science.